Meintest du:
Disorder1,403 Ergebnisse für: disorders
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?docid=212&vid=&lang=en&newsdate=201510&newsid=1955889&newslang=de
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
-
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological ... - Google Books
https://books.google.de/books?id=XY1DAAAAQBAJ&pg=PA14&dq=dse+dsi+synapse+-wiki&hl=de&sa=X&ved=0ahUKEwj62aOIvYHUAhVJORQKHSOnDIQQ6
The past decade has seen tremendous growth in the study of cannabinoid receptor signaling in brain. The impact and consequences of cannabinoid modulation of monoaminergic (dopamine, norepinephrine, and serotonin) circuits is becoming more clear. Scientists…
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?mid=19&vid=&lang=en
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
-
ZDB-Katalog - Suchergebnisseite: iss="0885-3185"
https://zdb-katalog.de/list.xhtml?t=iss%3D%220885-3185%22&key=cql
ZDB Zeitschriftendatenbank
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?docid=212&vid=&lang=en&newsdate=201510&newsid=1955888&newslang=en
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?docid=212&vid=&lang=en&newsdate=201509&newsid=1950678&newslang=en
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?docid=212&vid=&lang=en&newsdate=201509&newsid=1950679&newslang=de
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
-
Personality Disorders: New Symptom-focused Drug Therapy - Sonny Joseph - Google Books
https://books.google.de/books?hl=de&id=KEoPC3_1AGAC&printsec=toc#v
Using 50 pharmacological case studies, Personality Disorders illustrates how chronic and difficult psychiatric disorders ranging from paranoid to obsessive-compulsive personality disorder can be responsive to treatment. Readers are first taught to…
-
ZDB-Katalog - Suchergebnisseite: iss="1573-2517"
https://zdb-katalog.de/list.xhtml?t=iss%3D%221573-2517%22&key=cql
ZDB Zeitschriftendatenbank
-
Lysosomal Storage Disorders - Google Books
https://books.google.de/books?id=18xeMkdzF0kC
Scientific progress has been rapid in lysosomal biology during the last six decades. Its application to human disease is nothing less than spectacular. In no other group of disorders has knowledge and clinical utility progressed so speedily. Recall that…